Global Biosynthesis Peptide Drugs Market Growth (Status and Outlook) 2026-2032

May 2026 | 71 pages | ID: G09FD82B4542EN
LP Information

Abstracts

The global Biosynthesis Peptide Drugs market size is predicted to grow from US$ 18870 million in 2025 to US$ 28950 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.

Biosynthesis peptide drugs refer to pharmaceuticals that are produced using biotechnology and genetic engineering techniques. These drugs are created by synthesizing peptides through living organisms, such as bacteria, yeast, or mammalian cells, which have been genetically modified to express specific peptide sequences. This approach allows for the large-scale production of complex and bioactive peptides.

Biosynthesis peptide drugs are a prominent segment in today's pharmaceutical industry. The market size is steadily expanding, with significant growth in sales, primarily used in the treatment of various diseases such as diabetes, cancer, and immune-related disorders. These drugs mimic naturally occurring peptides in the body, exerting unique therapeutic effects on specific diseases. Future development trends indicate ongoing innovation in the field of biosynthesis peptide drugs, with the potential emergence of more efficient and precise treatment options, contributing to the continuous advancement of medical technology.

LPI (LP Information)' newest research report, the “Biosynthesis Peptide Drugs Industry Forecast” looks at past sales and reviews total world Biosynthesis Peptide Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Biosynthesis Peptide Drugs sales for 2026 through 2032. With Biosynthesis Peptide Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biosynthesis Peptide Drugs industry.

This Insight Report provides a comprehensive analysis of the global Biosynthesis Peptide Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biosynthesis Peptide Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biosynthesis Peptide Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biosynthesis Peptide Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biosynthesis Peptide Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Biosynthesis Peptide Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Dulaglutide
• Semaglutide
• Insulin Glargine
• Insulin Aspart
• Liraglutide

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novo Nordisk
• AstraZeneca
• Eli Lily
• Sanofi

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Biosynthesis Peptide Drugs Market Size (2021-2032)
  2.1.2 Biosynthesis Peptide Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Biosynthesis Peptide Drugs by Country/Region (2021, 2025 & 2032)
2.2 Biosynthesis Peptide Drugs Segment by Type
  2.2.1 Dulaglutide
  2.2.2 Semaglutide
  2.2.3 Insulin Glargine
  2.2.4 Insulin Aspart
  2.2.5 Liraglutide
  2.2.6 Biosynthesis Peptide Drugs Market Size by Type
    2.2.6.1 Biosynthesis Peptide Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.6.2 Global Biosynthesis Peptide Drugs Market Size Market Share by Type (2021-2026)
2.3 Biosynthesis Peptide Drugs Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 Biosynthesis Peptide Drugs Market Size by Application
    2.3.4.1 Biosynthesis Peptide Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Biosynthesis Peptide Drugs Market Size Market Share by Application (2021-2026)

3 BIOSYNTHESIS PEPTIDE DRUGS MARKET SIZE BY PLAYER

3.1 Biosynthesis Peptide Drugs Market Size Market Share by Player
  3.1.1 Global Biosynthesis Peptide Drugs Revenue by Player (2021-2026)
  3.1.2 Global Biosynthesis Peptide Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Biosynthesis Peptide Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BIOSYNTHESIS PEPTIDE DRUGS BY REGION

4.1 Biosynthesis Peptide Drugs Market Size by Region (2021-2026)
4.2 Global Biosynthesis Peptide Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biosynthesis Peptide Drugs Market Size Growth (2021-2026)
4.4 APAC Biosynthesis Peptide Drugs Market Size Growth (2021-2026)
4.5 Europe Biosynthesis Peptide Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Biosynthesis Peptide Drugs Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Biosynthesis Peptide Drugs Market Size by Country (2021-2026)
5.2 Americas Biosynthesis Peptide Drugs Market Size by Type (2021-2026)
5.3 Americas Biosynthesis Peptide Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Biosynthesis Peptide Drugs Market Size by Region (2021-2026)
6.2 APAC Biosynthesis Peptide Drugs Market Size by Type (2021-2026)
6.3 APAC Biosynthesis Peptide Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Biosynthesis Peptide Drugs Market Size by Country (2021-2026)
7.2 Europe Biosynthesis Peptide Drugs Market Size by Type (2021-2026)
7.3 Europe Biosynthesis Peptide Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Biosynthesis Peptide Drugs by Region (2021-2026)
8.2 Middle East & Africa Biosynthesis Peptide Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Biosynthesis Peptide Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BIOSYNTHESIS PEPTIDE DRUGS MARKET FORECAST

10.1 Global Biosynthesis Peptide Drugs Forecast by Region (2027-2032)
  10.1.1 Global Biosynthesis Peptide Drugs Forecast by Region (2027-2032)
  10.1.2 Americas Biosynthesis Peptide Drugs Forecast
  10.1.3 APAC Biosynthesis Peptide Drugs Forecast
  10.1.4 Europe Biosynthesis Peptide Drugs Forecast
  10.1.5 Middle East & Africa Biosynthesis Peptide Drugs Forecast
10.2 Americas Biosynthesis Peptide Drugs Forecast by Country (2027-2032)
  10.2.1 United States Market Biosynthesis Peptide Drugs Forecast
  10.2.2 Canada Market Biosynthesis Peptide Drugs Forecast
  10.2.3 Mexico Market Biosynthesis Peptide Drugs Forecast
  10.2.4 Brazil Market Biosynthesis Peptide Drugs Forecast
10.3 APAC Biosynthesis Peptide Drugs Forecast by Region (2027-2032)
  10.3.1 China Biosynthesis Peptide Drugs Market Forecast
  10.3.2 Japan Market Biosynthesis Peptide Drugs Forecast
  10.3.3 Korea Market Biosynthesis Peptide Drugs Forecast
  10.3.4 Southeast Asia Market Biosynthesis Peptide Drugs Forecast
  10.3.5 India Market Biosynthesis Peptide Drugs Forecast
  10.3.6 Australia Market Biosynthesis Peptide Drugs Forecast
10.4 Europe Biosynthesis Peptide Drugs Forecast by Country (2027-2032)
  10.4.1 Germany Market Biosynthesis Peptide Drugs Forecast
  10.4.2 France Market Biosynthesis Peptide Drugs Forecast
  10.4.3 UK Market Biosynthesis Peptide Drugs Forecast
  10.4.4 Italy Market Biosynthesis Peptide Drugs Forecast
  10.4.5 Russia Market Biosynthesis Peptide Drugs Forecast
10.5 Middle East & Africa Biosynthesis Peptide Drugs Forecast by Region (2027-2032)
  10.5.1 Egypt Market Biosynthesis Peptide Drugs Forecast
  10.5.2 South Africa Market Biosynthesis Peptide Drugs Forecast
  10.5.3 Israel Market Biosynthesis Peptide Drugs Forecast
  10.5.4 Turkey Market Biosynthesis Peptide Drugs Forecast
10.6 Global Biosynthesis Peptide Drugs Forecast by Type (2027-2032)
10.7 Global Biosynthesis Peptide Drugs Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Biosynthesis Peptide Drugs Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novo Nordisk
  11.1.1 Novo Nordisk Company Information
  11.1.2 Novo Nordisk Biosynthesis Peptide Drugs Product Offered
  11.1.3 Novo Nordisk Biosynthesis Peptide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Novo Nordisk Main Business Overview
  11.1.5 Novo Nordisk Latest Developments
11.2 AstraZeneca
  11.2.1 AstraZeneca Company Information
  11.2.2 AstraZeneca Biosynthesis Peptide Drugs Product Offered
  11.2.3 AstraZeneca Biosynthesis Peptide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 AstraZeneca Main Business Overview
  11.2.5 AstraZeneca Latest Developments
11.3 Eli Lily
  11.3.1 Eli Lily Company Information
  11.3.2 Eli Lily Biosynthesis Peptide Drugs Product Offered
  11.3.3 Eli Lily Biosynthesis Peptide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Eli Lily Main Business Overview
  11.3.5 Eli Lily Latest Developments
11.4 Sanofi
  11.4.1 Sanofi Company Information
  11.4.2 Sanofi Biosynthesis Peptide Drugs Product Offered
  11.4.3 Sanofi Biosynthesis Peptide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Sanofi Main Business Overview
  11.4.5 Sanofi Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Biosynthesis Peptide Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biosynthesis Peptide Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Dulaglutide
Table 4. Major Players of Semaglutide
Table 5. Major Players of Insulin Glargine
Table 6. Major Players of Insulin Aspart
Table 7. Major Players of Liraglutide
Table 8. Biosynthesis Peptide Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Biosynthesis Peptide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Biosynthesis Peptide Drugs Market Size Market Share by Type (2021-2026)
Table 11. Biosynthesis Peptide Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Biosynthesis Peptide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Biosynthesis Peptide Drugs Market Size Market Share by Application (2021-2026)
Table 14. Global Biosynthesis Peptide Drugs Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Biosynthesis Peptide Drugs Revenue Market Share by Player (2021-2026)
Table 16. Biosynthesis Peptide Drugs Key Players Head office and Products Offered
Table 17. Biosynthesis Peptide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Biosynthesis Peptide Drugs Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Biosynthesis Peptide Drugs Market Size Market Share by Region (2021-2026)
Table 22. Global Biosynthesis Peptide Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Biosynthesis Peptide Drugs Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Biosynthesis Peptide Drugs Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Biosynthesis Peptide Drugs Market Size Market Share by Country (2021-2026)
Table 26. Americas Biosynthesis Peptide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Biosynthesis Peptide Drugs Market Size Market Share by Type (2021-2026)
Table 28. Americas Biosynthesis Peptide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Biosynthesis Peptide Drugs Market Size Market Share by Application (2021-2026)
Table 30. APAC Biosynthesis Peptide Drugs Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Biosynthesis Peptide Drugs Market Size Market Share by Region (2021-2026)
Table 32. APAC Biosynthesis Peptide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Biosynthesis Peptide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Biosynthesis Peptide Drugs Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Biosynthesis Peptide Drugs Market Size Market Share by Country (2021-2026)
Table 36. Europe Biosynthesis Peptide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Biosynthesis Peptide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Biosynthesis Peptide Drugs Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Biosynthesis Peptide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Biosynthesis Peptide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Biosynthesis Peptide Drugs
Table 42. Key Market Challenges & Risks of Biosynthesis Peptide Drugs
Table 43. Key Industry Trends of Biosynthesis Peptide Drugs
Table 44. Global Biosynthesis Peptide Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Biosynthesis Peptide Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Biosynthesis Peptide Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Biosynthesis Peptide Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Novo Nordisk Details, Company Type, Biosynthesis Peptide Drugs Area Served and Its Competitors
Table 49. Novo Nordisk Biosynthesis Peptide Drugs Product Offered
Table 50. Novo Nordisk Biosynthesis Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Novo Nordisk Main Business
Table 52. Novo Nordisk Latest Developments
Table 53. AstraZeneca Details, Company Type, Biosynthesis Peptide Drugs Area Served and Its Competitors
Table 54. AstraZeneca Biosynthesis Peptide Drugs Product Offered
Table 55. AstraZeneca Biosynthesis Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. AstraZeneca Main Business
Table 57. AstraZeneca Latest Developments
Table 58. Eli Lily Details, Company Type, Biosynthesis Peptide Drugs Area Served and Its Competitors
Table 59. Eli Lily Biosynthesis Peptide Drugs Product Offered
Table 60. Eli Lily Biosynthesis Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Eli Lily Main Business
Table 62. Eli Lily Latest Developments
Table 63. Sanofi Details, Company Type, Biosynthesis Peptide Drugs Area Served and Its Competitors
Table 64. Sanofi Biosynthesis Peptide Drugs Product Offered
Table 65. Sanofi Biosynthesis Peptide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Sanofi Main Business
Table 67. Sanofi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Biosynthesis Peptide Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosynthesis Peptide Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biosynthesis Peptide Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biosynthesis Peptide Drugs Sales Market Share by Country/Region (2025)
Figure 8. Biosynthesis Peptide Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biosynthesis Peptide Drugs Market Size Market Share by Type in 2025
Figure 10. Biosynthesis Peptide Drugs in Hospital
Figure 11. Global Biosynthesis Peptide Drugs Market: Hospital (2021-2026) & ($ millions)
Figure 12. Biosynthesis Peptide Drugs in Clinic
Figure 13. Global Biosynthesis Peptide Drugs Market: Clinic (2021-2026) & ($ millions)
Figure 14. Biosynthesis Peptide Drugs in Other
Figure 15. Global Biosynthesis Peptide Drugs Market: Other (2021-2026) & ($ millions)
Figure 16. Global Biosynthesis Peptide Drugs Market Size Market Share by Application in 2025
Figure 17. Global Biosynthesis Peptide Drugs Revenue Market Share by Player in 2025
Figure 18. Global Biosynthesis Peptide Drugs Market Size Market Share by Region (2021-2026)
Figure 19. Americas Biosynthesis Peptide Drugs Market Size 2021-2026 ($ millions)
Figure 20. APAC Biosynthesis Peptide Drugs Market Size 2021-2026 ($ millions)
Figure 21. Europe Biosynthesis Peptide Drugs Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Biosynthesis Peptide Drugs Market Size 2021-2026 ($ millions)
Figure 23. Americas Biosynthesis Peptide Drugs Value Market Share by Country in 2025
Figure 24. United States Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Biosynthesis Peptide Drugs Market Size Market Share by Region in 2025
Figure 29. APAC Biosynthesis Peptide Drugs Market Size Market Share by Type (2021-2026)
Figure 30. APAC Biosynthesis Peptide Drugs Market Size Market Share by Application (2021-2026)
Figure 31. China Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. India Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Biosynthesis Peptide Drugs Market Size Market Share by Country in 2025
Figure 38. Europe Biosynthesis Peptide Drugs Market Size Market Share by Type (2021-2026)
Figure 39. Europe Biosynthesis Peptide Drugs Market Size Market Share by Application (2021-2026)
Figure 40. Germany Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. France Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Biosynthesis Peptide Drugs Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Biosynthesis Peptide Drugs Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Biosynthesis Peptide Drugs Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Biosynthesis Peptide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 54. APAC Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 55. Europe Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 57. United States Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 58. Canada Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 59. Mexico Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 60. Brazil Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 61. China Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 62. Japan Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 63. Korea Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 65. India Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 66. Australia Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 67. Germany Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 68. France Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 69. UK Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 70. Italy Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 71. Russia Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 72. Egypt Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 73. South Africa Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 74. Israel Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 75. Turkey Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)
Figure 76. Global Biosynthesis Peptide Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Biosynthesis Peptide Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Biosynthesis Peptide Drugs Market Size 2027-2032 ($ millions)